Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes (Q47296454)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes |
scientific article |
Statements
1 reference
Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes (English)
1 reference
1 reference
Tina Vilsbøll
1 reference
Milan Zdravkovic
1 reference
Tu Le-Thi
1 reference
Thure Krarup
1 reference
Ole Schmitz
1 reference
Jean-Pierre Courrèges
1 reference
Robert Verhoeven
1 reference
Ingrid Bugánová
1 reference
19 March 2007
1 reference
1 reference
30
1 reference
6
1 reference
1608-1610
1 reference
Identifiers
1 reference
1 reference